In this episode, we talk to Dr. Andrée Bates, founder and CEO of Eularis, a company helping clients accelerate pharma business results through Artificial Intelligence.

We explore how the biopharma industry can move beyond scattered pilots toward strategic, enterprise-wide AI integration. Drawing on decades at the forefront of AI in pharma, Dr. Bates shares practical insights on building the foundations for long-term value creation and turning AI into a true competitive advantage. We also dig into how to calculate ROI on AI, avoid the “spray and pray” trap, and why the future of pharma might look more like science fiction than we think.

If you want to connect with us - we would love to hear from you:

Linkedin: https://www.linkedin.com/company/cures-capital-podcast

You can also watch this episode on YouTube, just search for Cures & Capital.

If you want to connect withDr. Andrée Bates:

Linkedin: https://www.linkedin.com/in/dr-andree-bates/

Or get in touch with Eularis:

Linkedin: https://www.linkedin.com/company/eularis/

Website: https://eularis.com

If you would like to read Romy & Roby:

Website: https://romyandroby.ai

Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.